Prognostic value of using FeNO to guide step-down treatment decisions in asthma
<p><strong>Introduction:</strong> Use of fractional exhaled nitric oxide (FeNO) is recommended for asthma diagnosis but its role in guiding safe reduction of inhaled corticosteroids (ICS) is unclear.</p> <p><strong>Aims and objectives:</strong> To assess the...
Prif Awduron: | Wang, K, Verbakel, J, Fleming-Nouri, A, Brewin, J, Oke, J, Pavord, I, Thomas, M |
---|---|
Fformat: | Conference item |
Cyhoeddwyd: |
European Respiratory Society
2018
|
Eitemau Tebyg
-
Prognostic value of FeNO-guided assessment to identify steroid-responsive respiratory symptoms
gan: Wang, K, et al.
Cyhoeddwyd: (2018) -
Using fractional exhaled nitric oxide to guide step down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis
gan: Wang, K, et al.
Cyhoeddwyd: (2020) -
Update on the Role of FeNO in Asthma Management
gan: Neveda Murugesan, et al.
Cyhoeddwyd: (2023-04-01) -
The reliability of adjusting stepped care based on FeNO monitoring for patients with chronic persistent asthma
gan: Wang Xiaoru, et al.
Cyhoeddwyd: (2019-02-01) -
The change of FeNO is correlated with asthma control and lung function
gan: Yanmin Gao, et al.
Cyhoeddwyd: (2024-10-01)